title: Restricting topical ocular chloramphenicol eye drop use in the United States. Did we overreact?
authors: Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon. Electronic address: fraunfer@ohsu.edu.
authors: Frederick W
authors: FW
authors: Fraunfelder
authors: Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon.
authors: Frederick T
authors: FT
authors: Fraunfelder
mesh_terms: D000287:Administration, Topical; D016907:Adverse Drug Reaction Reporting Systems; D000741:Anemia, Aplastic / Q000139:chemically induced / Q000401:mortality; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002701:Chloramphenicol / Q000008:administration & dosage* / Q000009:adverse effects; D015818:Eye Infections, Bacterial / Q000188:drug therapy; D006801:Humans; D057970:Inappropriate Prescribing; D007880:Legislation, Drug; D009883:Ophthalmic Solutions; D010265:Paraproteinemias / Q000139:chemically induced / Q000401:mortality; D010818:Practice Patterns, Physicians'; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents; D009883:Ophthalmic Solutions; D002701:Chloramphenicol